Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2021
Reporting Period: Three months ended March 31, 2021
This filing serves as a notification that the Company issued a press release on May 6, 2021, announcing financial results for the quarter ended March 31, 2021. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The filing states that revenue, profit, cash flow, margins, debt, and liquidity figures are detailed in the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific values can be reported from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only references the announcement of results for the three months ended March 31, 2021.
Guidance, Outlook, and Risks
Management Commentary: The Company scheduled a conference call for 8:00 AM ET on May 6, 2021, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2021.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check the conference call transcript for management's outlook and guidance for the remainder of fiscal 2021.
- Confirm liquidity position and debt covenants in the full financial statements referenced in the press release.